Does GALSULFASE Cause Infusion site extravasation? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Infusion site extravasation have been filed in association with GALSULFASE (NAGLAZYME). This represents 0.3% of all adverse event reports for GALSULFASE.
8
Reports of Infusion site extravasation with GALSULFASE
0.3%
of all GALSULFASE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Infusion site extravasation From GALSULFASE?
Of the 8 reports.
Is Infusion site extravasation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GALSULFASE. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does GALSULFASE Cause?
Pyrexia (338)
Pneumonia (197)
Cough (181)
Dyspnoea (154)
Spinal cord compression (108)
Vomiting (106)
Oxygen saturation decreased (100)
Fatigue (92)
Pain (81)
Headache (75)
What Other Drugs Cause Infusion site extravasation?
HUMAN IMMUNOGLOBULIN G (822)
INFLIXIMAB (435)
INFLIXIMAB-DYYB (328)
TREPROSTINIL (256)
VEDOLIZUMAB (199)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (185)
REMDESIVIR (144)
FERRIC CARBOXYMALTOSE (118)
RITUXIMAB (82)
NATALIZUMAB (70)
Which GALSULFASE Alternatives Have Lower Infusion site extravasation Risk?
GALSULFASE vs GAMMAGARD LIQUID
GALSULFASE vs GANAXOLONE
GALSULFASE vs GANCICLOVIR
GALSULFASE vs GANIRELIX
GALSULFASE vs GATIFLOXACIN